Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott Diabetes Care and Bayer having a ...

French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

While Sanofi is winding up its R&D operations in diabetes it is turning to digital solutions to get the most from its established products for the disease. With this deal Health2Sync becomes one ...

Sanofi engages in the research ... specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities.

Sanofi India on Tuesday said it has launched its diabetes drug Soliqua in the country. The company introduced the medication after receiving the marketing authorisation from the Central Drugs ...

Sanofi India net profit down 46% in quarter ended September 30: Our Bureau, New Delhi Friday, November 8, 2024, 11:35 Hrs [IST] Sanofi India has registered 46 per cent decline in ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price ...

Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...